Skip to content
Home/Companies/Biotech/Nuntius Therapeutics
NT

Nuntius Therapeutics

Biotech·UK·Active·5yr hold

Nuntius Therapeutics is a biotech company, headquartered in UK.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Nuntius Therapeutics?

Nuntius Therapeutics is currently owned by BACKED VC through Backed Fund II (2022 vintage), since 2021.

Hand-verified · updated 2026-05-27

BACKED VC
Investor
BACKED VC
Backed Fund II · 2022 · VC

Key facts

HQUK
SectorBiotech
StatusActive

More from Backed Fund II

Other portfolio companies in the same fund.

Auctor
Active
FintechSingapore· 2022
BCB Group
Active
FintechUK· 2022
CoSyne Therapeutics
Active
BiotechUK· 2022
Footium
Active
GamingUK· 2022
Laguna Games
Active
GamingUSA· 2022
Onramper
Active
FintechNetherlands· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings